MA23036A1 - PROCESS FOR THE PREPARATION OF COMPOUNDS. - Google Patents

PROCESS FOR THE PREPARATION OF COMPOUNDS.

Info

Publication number
MA23036A1
MA23036A1 MA23342A MA23342A MA23036A1 MA 23036 A1 MA23036 A1 MA 23036A1 MA 23342 A MA23342 A MA 23342A MA 23342 A MA23342 A MA 23342A MA 23036 A1 MA23036 A1 MA 23036A1
Authority
MA
Morocco
Prior art keywords
compounds
preparation
Prior art date
Application number
MA23342A
Other languages
French (fr)
Inventor
Alan Levy Mark
Alan Holt Dennis
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929224213A external-priority patent/GB9224213D0/en
Priority claimed from GB939316954A external-priority patent/GB9316954D0/en
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA23036A1 publication Critical patent/MA23036A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0014—Androstane derivatives substituted in position 17 alfa, not substituted in position 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
MA23342A 1992-11-18 1993-11-17 PROCESS FOR THE PREPARATION OF COMPOUNDS. MA23036A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224213A GB9224213D0 (en) 1992-11-18 1992-11-18 Compounds
GB939316954A GB9316954D0 (en) 1993-08-14 1993-08-14 Compounds

Publications (1)

Publication Number Publication Date
MA23036A1 true MA23036A1 (en) 1994-07-01

Family

ID=26302003

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23342A MA23036A1 (en) 1992-11-18 1993-11-17 PROCESS FOR THE PREPARATION OF COMPOUNDS.

Country Status (12)

Country Link
EP (2) EP0669932A4 (en)
JP (1) JPH08503471A (en)
CN (2) CN1101916A (en)
AP (1) AP9300589A0 (en)
AU (2) AU5671794A (en)
CA (1) CA2149427A1 (en)
IL (1) IL107611A0 (en)
MA (1) MA23036A1 (en)
MX (1) MX9307203A (en)
NZ (1) NZ258723A (en)
SI (1) SI9300601A (en)
WO (2) WO1994011004A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
GB9415178D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 4-azasteroids with side-chain fluoroketones
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
EP0784627A4 (en) * 1994-10-05 1998-05-06 Smithkline Beecham Corp Process for preparing 17-beta-substituted-androsta-3,5-dien-3-carboxylic acids
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
ES2222614T3 (en) 1997-11-12 2005-02-01 Mitsubishi Chemical Corporation DERIVATIVES OF PURINE AND MEDICINE THAT CONTAINS THEM AS ACTIVE INGREDIENT.
CN1160355C (en) 1999-05-11 2004-08-04 三菱化学株式会社 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
FR2817257B1 (en) 2000-11-30 2009-03-20 Sanofi Synthelabo CYCLOHEXYL (ALKYL) -PROPANOLAMINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041433A (en) * 1987-04-29 1991-08-20 Smithkline Beecham Corporation 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US4954446A (en) * 1988-05-25 1990-09-04 Smithkline Beecham Corporation Aromatic steroid 5-α-reductase inhibitors
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5137882A (en) * 1990-06-11 1992-08-11 Holt Dennis A Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors
CA2045865A1 (en) * 1990-06-28 1991-12-29 Gary H. Rasmusson Intermediates on the synthesis of 17 beta-acyl-3-carboxy-androsta-3,5-dienes
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
CA2045866A1 (en) * 1990-06-28 1991-12-29 Gary H. Rasmusson 17-beta-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5 alpha-reductase inhibitors
US5196411A (en) * 1991-08-16 1993-03-23 Merck & Co., Inc. 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors

Also Published As

Publication number Publication date
AP9300589A0 (en) 1994-01-31
JPH08503471A (en) 1996-04-16
CA2149427A1 (en) 1994-05-26
NZ258723A (en) 1996-12-20
CN1101916A (en) 1995-04-26
WO1994011386A1 (en) 1994-05-26
EP0669932A4 (en) 1995-10-25
IL107611A0 (en) 1994-02-27
EP0673251A1 (en) 1995-09-27
SI9300601A (en) 1994-06-30
EP0669932A1 (en) 1995-09-06
EP0673251A4 (en) 1995-10-25
AU5613394A (en) 1994-06-08
WO1994011004A1 (en) 1994-05-26
AU5671794A (en) 1994-06-08
MX9307203A (en) 1994-07-29
CN1101914A (en) 1995-04-26

Similar Documents

Publication Publication Date Title
MA22922A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA23270A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA22923A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
FR2691326B1 (en) PROCESS FOR THE PRODUCTION OF ANTIMICROBIAL COMPOUNDS.
MA23143A1 (en) PROCESS FOR THE PREPARATION OF VACCINATION COMPOSITIONS.
MA22970A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA23792A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
MA24011A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
RO91184A (en) PROCESS FOR THE PREPARATION OF 2,2'-IMINOBISETHANOL DERIVATIVES
MA23802A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
MA22955A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA23254A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
FR2740132B1 (en) PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTAFLUOROPROPANE
MA22860A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA21962A1 (en) PROCESS FOR THE PREPARATION OF RETROVIRAL PROTEASS INHIBITORS.
MA23041A1 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED BENZOPYRANIC COMPOUNDS.
MA23309A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA23017A1 (en) PROCESS FOR THE PREPARATION OF CHEMICAL COMPOUNDS.
MA23134A1 (en) PROCESS FOR THE PREPARATION OF ARYL-PIPERIDINE CARBINOLS.
MA23036A1 (en) PROCESS FOR THE PREPARATION OF COMPOUNDS.
MA22848A1 (en) ENZYMATIC PROCESS FOR THE PREPARATION OF ARYL-PIPERIDINES
MA21984A1 (en) PROCESS FOR THE PREPARATION OF QUILINONE DERIVATIVES.
MA22927A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA24015A1 (en) PROCESS FOR THE PREPARATION OF DIOXO-AZABICYCLOHEXANES
FR2688001B1 (en) PROCESS FOR THE PREPARATION OF P-AMINOPHENOLS.